Rebecca Bechhold to Middle Aged
This is a "connection" page, showing publications Rebecca Bechhold has written about Middle Aged.
Connection Strength
0.027
-
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score. Breast Cancer Res Treat. 2015 Nov; 154(2):299-308.
Score: 0.009
-
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer. J Clin Oncol. 2015 May 10; 33(14):1609-19.
Score: 0.009
-
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute. Clin Breast Cancer. 2015 Aug; 15(4):251-8.
Score: 0.009